Home > Find an expert

Prof. Jacob Hochman

Researcher interests: The relation between cell adhesiveness and growth control in malignant lymphoma cells. Molecular mechanisms involved in the selection of non-malignant variant cells from malignant cell populations. Different approaches to reversal of multi-drug resistance
FACULTY / SCHOOL: Faculty of Science
Contact Business Development: Mel Larrosa
All projects by researcher: Immunotherapy using Antibodies for p14 Related Breast Cancer | Vaccine Development Monoclonal Antibodies Directed Against Signal Peptide
Cell Biology (44)Molecular mechanisms (3)

Selected Publications

andrea fontana, antonio giuseppe naccarato, chiara maria mazzanti, claudia de angelis, claudia scopelliti, cristian scatena, davide pellegrini, elena tantillo, francesca lessi, Jacob Hochman, i bertolini, ivo marchetti, l diodati, liam a mcdonnell, m roncella, marco la ferla, marzia del re, michele menicagli, paolo aretini, prospero civita, sara franceschi
ankrd44 gene silencing a putative role in trastuzumab resistance in her2 like breast cancer (2019)| Frontiers in Oncology| Read more
asaad gammal, edit y tshuva, Jacob Hochman, nitzan ganot, ori briaitbard, Joseph Tam
in vivo anticancer activity of a nontoxic inert phenolato titanium complex high efficacy on solid tumors alone and combined with platinum drugs (2018)| ChemMedChem| Read more
edit y tshuva, Jacob Hochman, Lilia Reytman
anticancer diaminotris phenolato vanadium v complexes ligand metal interplay (2018)| Journal of Coordination Chemistry| Read more
benafsha yosufi, chiara maria mazzanti, christopher c ngan, Jacob Hochman, james s lawson, m menicagli, noel j whitaker, Ori Braitbard, prospero civita, wendy k glenn
association of mouse mammary tumor virus with human breast cancer histology immunohistochemistry and polymerase chain reaction analyses (2018)| Frontiers in Oncology| Read more
edit y tshuva, Jacob Hochman, maya miller, Ori Braitbard
insights into molecular mechanism of action of salan titanium iv complex with in vitro and in vivo anticancer activity (2016)| Journal of Inorganic Biochemistry| Read more
edit y tshuva, Jacob Hochman, matthew d hall, Ori Braitbard, Sigalit Meker
specific design of titanium iv phenolato chelates yields stable and accessible effective and selective anticancer agents (2016)| Chemistry: A European Journal| Read more
edit y tshuva, Jacob Hochman, matthew d hall, Ori Braitbard, Sigalit Meker
cover picture specific design of titanium iv phenolato chelates yields stable and accessible effective and selective anticancer agents chem eur j 29 2016 (2016)| Chemistry: A European Journal| Read more
allan barsinai, antonio giuseppe naccarato, chiara mazzanti, dana rajchman, francesca lessi, generoso bevilacqua, hillel abramovitch, Jacob Hochman, Maayan Roniger, marco la ferla, Ori Braitbard, sara franceschi, tamar gross
a new immunization and treatment strategy for mouse mammary tumor virus mmtv associated cancers (2016)| Oncotarget| Read more
edit y tshuva, Jacob Hochman, Lilia Reytman, Ori Braitbard
highly effective and hydrolytically stable vanadium v amino phenolato antitumor agents (2016)| Inorganic Chemistry| Read more
edit y tshuva, Jacob Hochman, katrin margulisgoshen, Shlomo Magdassi, Ori Braitbard, Sigalit Meker
highly stable tetra phenolato titanium iv agent formulated into nanoparticles demonstrates anti tumoral activity and selectivity (2015)| Molecules| Read more

Contact for more information:

Mel Larrosa
VP Business Development Healthcare
+972-2-6586692
Contact ME: